Acalculous Cholecystitis Market Share 2023: Analysis of Epidemiology, Industry Trends, Size, and Future Forecast by 2033

IMARC Group has recently released a report titled “Acalculous Cholecystitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033” that presents a comprehensive assessment of the acalculous cholecystitis market share, size, latest trends, and growth forecast. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends.

In addition, the report offers competitor analysis, regional analysis, and recent advancements in the global market. The report also highlights key segments and market drivers, as well as challenges faced by industry players.

Acalculous cholecystitis (AC) is a medical condition characterized by sudden inflammation and gallbladder swelling, occurring without gallstones or blockage in the cystic duct. Although the symptoms of acalculous cholecystitis can be comparable to those of calculous cholecystitis, no stones are found in the gallbladder in this particular case.

Some of the common signs that point towards acalculous cholecystitis include intense abdominal pain, which is primarily concentrated in the right upper quadrant or the epigastric region, along with nausea, vomiting, fever, jaundice, loss of appetite, and tenderness in the abdomen. In order to diagnose this ailment, physicians usually rely on a combination of clinical evaluation and imaging tests.

Request a Free Sample Report:

Market Trend:

The increasing incidences of several associated risk factors, such as gallbladder injury, bacterial infections, ischemia, etc., which cause gallbladder inflammation, are primarily driving the acalculous cholecystitis market. Additionally, the rising utilization of percutaneous cholecystostomy for draining the gallbladder to relieve symptoms of AC and prevent complications, including gangrene or perforation of the gallbladder, is stimulating the market growth.

Moreover, the increasing usage of magnetic resonance cholangiopancreatography (MRCP), a non-invasive imaging modality to visualize the bile ducts and pancreas for confirming AC in cases where the ultrasound is inconclusive, is creating a positive outlook for the market. Besides this, the widespread adoption of endoscopic retrograde cholangiopancreatography (ERCP) for identifying biliary obstruction, which can help alleviate symptoms and prevent complications, is augmenting the market growth.

Furthermore, the emerging popularity of laparoscopic cholecystectomy on account of its numerous associated benefits, such as reduced scarring, quicker recovery, and a shorter hospital stay compared to open surgery procedures, is expected to drive the acalculous cholecystitis market in the coming years.

Report Period:

  • Base Year: 2022
  • Historical Period: 2017-2022
  • Market Forecast: 2023-2033

Countries Included:

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the acalculous cholecystitis market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the acalculous cholecystitis market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures:

Key Questions Answered in this Report:

  • How has the acalculous cholecystitis market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
  • What was the country-wise size of the acalculous cholecystitis market across the seven major markets in 2022 and what will it look like in 2033?
  • What is the growth rate of the acalculous cholecystitis market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?

Browse the Latest Research Report:

Significant Benefits of the Report to Stakeholders:

  • Individuals directly or indirectly involved in the value chain of the acalculous cholecystitis market can gain valuable insights into key players and major market trends, enabling them to stay up-to-date and make informed decisions.
  • Professionals responsible for selecting a acalculous cholecystitis market for large and enterprise-level organizations can conduct thorough due diligence by leveraging the comprehensive information provided in this report.
  • Those seeking current intelligence on the dynamic acalculous cholecystitis market can benefit from the report’s valuable insights, helping them stay informed and make strategic business decisions.
  • Companies operating in the acalculous cholecystitis market can benchmark and assess their market position and standing against their competitors, gaining a strategic viewpoint to evaluate and adapt to the changing market landscape.

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

134 N 4th St.
Brooklyn, NY 11249, USA
Email: [email protected]
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800